{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:06:41Z","timestamp":1794200801355,"version":"4.8.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Liposomal amphotericin-B (L-AmB) prophylaxis is used in children with leukemia when azoles are contraindicated, but its effect is debated. We reviewed cases of invasive aspergillosis despite L-AmB 2.5\u2009mg\/kg twice weekly in children with high-risk leukemia during 2012-2019. Ten (16%) of 62 children had proven or probable aspergillosis. Thus, L-AmB prophylaxis offered insufficient protection for <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>, in particular for <jats:italic toggle=\"yes\">Aspergillus flavus<\/jats:italic>.<\/jats:p>","DOI":"10.1097\/inf.0000000000003189","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T13:00:09Z","timestamp":1626094809000},"page":"749-752","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Aspergillus flavus Infections in Children With Leukemia Despite Liposomal Amphotericin-B Prophylaxis"],"prefix":"10.1097","volume":"40","author":[{"given":"Nadja Hawwa","family":"Vissing","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Lausen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hutchings Hoffmann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Als-Nielsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"},{"name":"Department of Clinical Medicine, Copenhagen University, Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Helweg-Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Rigshospitalet, Copenhagen University HospitalRigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Copenhagen University, Copenhagen"},{"name":"Department of Infectious Diseases, Rigshospitalet, Copenhagen University HospitalRigshospitalet"},{"name":"Unit for Mycology, Statens Serum Institut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrikka","family":"Nygaard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-1161","article-title":"Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.","volume":"117","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases.","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic Antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients.","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.","volume":"72","author":"Cornely","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/AAC.49.2.512-517.2005","article-title":"Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.","volume":"49","author":"Hsueh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1469-0691.2011.03483.x","article-title":"Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.","volume":"17","author":"Bochennek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1439-0507.2001.00706.x","article-title":"Liposomal amphotericin B for prophylaxis of invasive fungal infections in high-risk paediatric patients with chemotherapy-related neutropenia: interim analysis of a prospective study.","volume":"44","author":"Uhlenbrock","year":"2001","journal-title":"Mycoses"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/dkp196","article-title":"Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation.","volume":"64","author":"Kolve","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diagmicrobio.2005.01.001","article-title":"Increased frequency of non-fumigatus Aspergillus species in amphotericin B\u2013 or triazole\u2013pre-exposed cancer patients with positive cultures for aspergilli.","volume":"52","author":"Lionakis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist Updat"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:00:52Z","timestamp":1750003252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003189","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,12]]}}}